Didanosine therapy in patients intolerant of or failing zidovudine therapy

scientific article published on November 1, 1992

Didanosine therapy in patients intolerant of or failing zidovudine therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/106002809202601101
P953full work available at URLhttp://www.theannals.com/cgi/content/abstract/26/11/1347
P698PubMed publication ID1362093

P2093author name stringE. S. Martin
R. C. Rathbun
P2860cites workHIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapyQ28339571
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosidesQ28360374
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialQ29620785
2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trialQ45190383
Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trialQ45875093
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectzidovudineQ198504
didanosineQ422606
P304page(s)1347-51
P577publication date1992-11-01
P1433published inAnnals of PharmacotherapyQ4767858
P1476titleDidanosine therapy in patients intolerant of or failing zidovudine therapy
P478volume26

Reverse relations

Q35610773Neuromuscular complications in HIV.cites workP2860